Angiokeratoma: a cutaneous marker of Fabry's disease

L M J Albano1, C Rivitti, D R Bertola

  • 1Clinical Genetics Unit, Instituto da Criança, Hospital das Clínicas, FMUSP, São Paulo, Brazil. lilian.albano@icr.usp.br

Insights

Fabry's disease (FD) can have subtle early symptoms like angiokeratoma, delaying diagnosis. Early skin lesion screening in at-risk individuals can help identify FD patients sooner.

Area of Science:

  • Dermatology
  • Genetics
  • Rare Diseases

Background:

  • Fabry's disease (FD) is a rare genetic disorder.
  • Initial symptoms of FD can be subtle, leading to diagnostic delays.

Purpose of the Study:

  • To assess the prevalence of FD in men with angiokeratoma.
  • To highlight the importance of dermatological screening for early FD detection.

Main Methods:

  • A survey and screening study was conducted.
  • Participants included men with biopsy-proven angiokeratoma and their relatives (n=29).

Main Results:

  • Three patients with Fabry's disease were identified.
  • Angiokeratoma was a significant early indicator in identified patients.

Conclusions:

  • Dermatologists should consider FD when encountering unexplained cutaneous vascular lesions.
  • Screening for FD in patients with angiokeratoma is crucial for timely diagnosis and management.